Confirms coverage and clears prior authorization needs for biologics, phototherapy, and Mohs surgery before the appointment happens.
Dermatology Medical Billing Services Built for Mohs, Biologics, and Excision Claims
From skin biopsies and lesion excisions to Mohs surgery, phototherapy, and biologic drug claims for psoriasis and eczema, we bill every corner of a dermatology practice.
🔒 100% confidential. We never sell your data. Privacy Policy
Thrive manages the billing side of your dermatology practice so your physicians can stay focused on patients instead of chasing payers. That means coding every biopsy, destruction, and excision by the correct procedure family, applying modifier 25 correctly when an E/M visit and a procedure happen the same day, and following up on every claim until it is paid or resolved.
Practices that choose dermatology medical billing company support from Thrive get a team that already knows lesion coding, Mohs staging, and biologic prior authorization, instead of a generalist biller treating every skin procedure the same way. Whether your practice is general dermatology, a Mohs surgery practice, or a mix of both, the coding rules overlap enough to share one trained team and diverge enough that generalist billers consistently get them wrong.
Dermatology billing services carry more procedure variety per visit than most specialties, biopsy, destruction, excision, pathology, and drug administration can all show up in a single encounter. Here is what we handle from the first eligibility check to the final payment.
Confirms coverage and clears prior authorization needs for biologics, phototherapy, and Mohs surgery before the appointment happens.
Secures and tracks authorization for biologic therapies, photodynamic therapy, and Mohs surgery across commercial and Medicare Advantage plans.
Checks every biopsy, destruction, and excision code against lesion count, size, and modifier requirements before a claim leaves the building.
Traces denials to their actual cause, whether a cosmetic reclassification or a missing modifier 25, and appeals with the documentation each payer requires.
Works open claims on a set schedule so biopsy, excision, and biologic balances do not sit past 30 days unattended.
Bills patients clearly for procedures payers classify as cosmetic, backed by proper documentation and ABN forms where required.
Reconciles biologic drug reimbursement against the actual dose administered, so cost overruns get caught early.
Keeps dermatologists and Mohs surgeons credentialed and enrolled with the payers your patients actually carry.
Regular reporting on claim status, denial trends, and AR aging broken out by procedure, biologic, and pathology claim categories.
A quick reference to how dermatology billing codes are organized, not a substitute for chart documentation. Useful for seeing where a specific claim fits before it is coded.
These are not generic billing problems. Each one is specific to how payers adjudicate dermatology and Mohs surgery claims.
The same excision covered when pathology confirms a malignancy gets denied as cosmetic when the same lesion turns out to be a benign cyst, even though the procedure performed was identical.
Billing an office visit on the same day as a biopsy or destruction without modifier 25, and without documentation showing the visit was separately identifiable, is one of the most common and costly dermatology denials.
Billing the base biopsy or destruction code multiple times instead of using the correct add-on code for each additional lesion triggers an automatic denial under payer editing rules.
Coding an excision by lesion size alone instead of the excised diameter, measured before anesthesia and including margins, systematically undercodes malignant excisions and underpays the practice.
Missing stage-by-stage margin documentation, or performing Mohs on a small, low-risk lesion that does not meet medical necessity criteria versus standard excision, both lead to denial or recoupment.
Psoriasis, atopic dermatitis, and hidradenitis suppurativa biologic claims are denied without documented step therapy failure, body surface area, and functional impairment on file before the prior authorization request.
Biologic and skin substitute drug claims submitted without a JW modifier for discarded drug or a JZ modifier confirming zero waste are treated as missing required information and denied.
Billing surgical pathology separately when it is already included in the Mohs code, or missing the technical and professional component split when an outside lab processes the specimen, causes denial or overpayment exposure.
Every step below exists because of a specific denial pattern above. Nothing here is generic.
Practices that switch to Thrive get a dermatology billing company built around lesion coding, Mohs staging, and biologic claims specifically, not generic revenue cycle coverage stretched across every specialty.
We will look at your current claim volume, denial patterns, and procedure mix, Mohs heavy, biologic heavy, or general, and put together a custom fee schedule and a revenue recovery estimate. No obligation.
🔒 100% confidential. We never sell your data. Privacy Policy
When high-volume visits, biopsies, pathology, payer edits, cosmetic exclusions, and old AR compete for attention, your team needs a cleaner billing workflow. Thrive can help you see where claims are slowing down in a free 15-minute Revenue Analysis.
At Thrive Medical Billing, we specialize in providing precise, efficient, and personalized medical billing services. As a trusted medical billing company, we are committed to helping your practice succeed by handling all your billing needs, allowing you to focus on what matters most—providing exceptional care to your patients. Partner with us to elevate your practice and experience growth—because when your practice thrives, so do we.
🔒 100% confidential. We never sell your data. Privacy Policy
Maximize Your Revenue with Expert Medical Billing & Coding Services
Fill out the form below, and let’s create a customized solution for your practice.